The DOI matches its Crossref record.
Urinary free cortisone and the assessment of 11β‐hydroxysteroid dehydrogenase activity in man
Abstract
OBJECTIVE: Two isoforms of 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) catalyse the interconversion of cortisol to hormonally inactive cortisone; defects in the 11 beta-HSD2 isoform result in hypertension. The kidney, expressing high levels of 11 beta-HSD2, is the principal source of cortisone in man. We have validated the measurement of urinary free cortisone (UFE) excretion in normals and in patients with disorders of the pitultary-adrenal axis in an attempt to more accurately measure the activity of 11 beta-HSD2 in vivo. SUBJECTS: Forty-one normal adults, 12 normal children < 12 years of age, 15 patients with Cushing's syndrome, 12 with hypopitultarism on replacement hydrocortisone, 12 with the syndrome of apparent mineralocorticoid excess (AME) and 7 volunteers consuming liquorice. MEASUREMENTS: A complete 24-hour urine collection was analysed by gas chromatography/mass spectrometry for "A-ring' reduced cortisol and cortisone metabolites, i.e. tetrahydrocortisols (THF and allo-THF) and tetrahydrocortisone (THE). In addition, urinary free cortisol (UFF) and urinary free cortisone were quantified using deuterium-labelled internal standards. RESULTS: In normal adults and children, UFE excretion exceeded that of UFF (UFF 30.4 +/- 2.4 micrograms/24h (mean +/- SE), UFE 54.6 +/- 4.1 micrograms/24h, adults) (for conversion to nmol/24h multiply E by 2.78 and F by 2.76 respectively). Thus the normal UFF/UFE ratio was 0.54 +/- 0.05 in contrast to the (THF + allo-THF)/THE ratio of 1.21 +/- 0.06. UFE excretion was normal in hypopituitary patients on replacement hydrocortisone. Although UFE was elevated in all forms of Cushing's syndrome, the UFF/UFE ratio was grossly elevated in patients with the ectopic ACTH syndrome (14.0 +/- 6.7, n = 6). UFE was below the lower limit of the assay (< 1 microgram/24h) in most patients with the so-called type 1 variant of AME and significantly reduced in 4 patients described as having the type 2 variant of AME (10.5 +/- 3.5 micrograms/h, P < 0.05) and in 7 volunteers consuming liquorice (26.8 +/- 10.0 micrograms/24h, P < 0.01). In ectopic ACTH syndrome, AME, and liquorice ingestion the UFF/UFE ratio was more deranged than the (THF + allo-THF)/THE ratio. CONCLUSION: In normals the discrepant THF + allo-THF/ THE and UFF/UFE ratio suggests that much more of the UFE is derived from the kidney. Reduction in UFE excretion is seen following liquorice ingestion and in both variants of AME, though it is more profound in AME1. The high UFF/UFE ratio in the mineralocorticoid excess state seen in the ectopic ACTH syndrome is compatible with substrate-saturation of renal 11 beta-HSD2. The measurement of UFE and the UFF/UFE ratio is a significant advance in the analysis of human 11 beta-HSD activity in vivo; in particular, the UFF/UFE ratio appears to be a more sensitive index than the (THF + allo-THF)/THE ratio of renal 11 beta-HSD2 activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The present study and previous data show higher salivary cortisol:cortisone ratios with increasing concentrations, indicating that higher levels of cortisol overwhelm the capacity of 11β-HSD2 in the salivary glands (23, 47).”
From Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test (2024) · cites this paper as [47]
In the citing paper
“The urinary free cortisol–to–urinary free cortisone ratio has emerged as a more sensitive marker for AME than the ratio of (THF+5α-THF)/THE (100), as A-ring reduction to tetrahydro metabolites takes place mainly in the liver and their ratio may not accurately reflect renal HSD11B2 activity.”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [100]
Citations
Cited by
Sorted by citations
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
“The urinary THF allo-THF:THE ratio, in the setting of a normal UFF and UFE excretion, is also believed to reflect global 11 -HSD1 activity (26).”
Self-citation11β-Hydroxysteroid Dehydrogenase
Stewart, P. M., & Krozowski, Z. S. (1997) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60646-9 · Cited by 723
Self-citationGlucocorticoids and the regulation of memory in health and disease
de Quervain, D. J. ‐., Aerni, A., Schelling, G., & Roozendaal, B. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.03.002 · Cited by 525
Reduced Cortisol Metabolism during Critical Illness
Boonen, E., Vervenne, H., Meersseman, P., Andrew, R., Mortier, L., Declercq, P. E., Vanwijngaerden, Y.-M., Spriet, I., Wouters, P. J., Vander Perre, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214969 · Cited by 477
Stewart, P. M., Boulton, A., Kumar, S., Clark, P. M. S., & Shackleton, C. H. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5538 · Cited by 398
“There was no change in the UFF/UFE ratio between groups, suggesting similar levels of 11bHSD2 (23) (Fig.”
Self-citation11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action
Draper, N., & Stewart, P. M. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06019 · Cited by 375
“In AME, UFE excretion is virtually undetectable (Palermo et al. 1996).”
BackgroundSelf-citationHypertension and the cortisol-cortisone shuttle
Quinkler, M., & Stewart, P. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030138 · Cited by 286
“Both the urinary ratio of THF allo-THF/THE and UFF/UFE are elevated, not because of impaired 11 -HSD2 activity, but simply because of substrate saturation.”
BackgroundMethodInfluentialSelf-citationHigh cardiovascular risk in patients with Cushing’s syndrome according to 1999 WHO/ISH guidelines
Mancini, T., Kola, B., Mantero, F., Boscaro, M., & Arnaldi, G. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02168.x · Cited by 278
“We recently observed inhibition of 11β hydroxysteroidodehydrogenase type 2 (11βHSD) in patients with CS (Palermo et al., 1996; Mancini et al., 2003).”
Self-citationAbnormal Cortisol Metabolism and Tissue Sensitivity to Cortisol in Patients with Glucose Intolerance
Andrews, R. C., Herlihy, O., Livingstone, D. E. W., Andrew, R., & Walker, B. R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020048 · Cited by 199
The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension
Ferrari, P. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.017 · Cited by 187
“The activity of the 11ßHSD2 enzyme can be reliably assessed in vivo by measuring the ratio of biologically active cortisol (F) to inactive cortisone (E), or their tetrahydrometabolites (THF and THE), in the urine by gas chromatography with mass spectrometry [29, 30].”
Westerbacka, J., Yki‐Järvinen, H., Vehkavaara, S., Häkkinen, A., Andrew, R., Wake, D. J., Seckl, J. R., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030596 · Cited by 176
Cortisol metabolism and the role of 11β-hydroxysteroid dehydrogenase
Tomlinson, J., & Stewart, P. M. (2001) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2000.0119 · Cited by 165
Self-citationValsamakis, G., Anwar, A., Tomlinson, J., Shackleton, C. H. L., McTernan, P. G., Chetty, R., Wood, P. J., Banerjee, A. K., Holder, G., Barnett, A. H., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032240 · Cited by 156
Self-citationExpression and functional consequences of 11β-hydroxysteroid dehydrogenase activity in human bone
Cooper, M. S., Walker, E. A., Bland, R., Fraser, W. D., Hewison, M., & Stewart, P. M. (2000) · Bone · doi:10.1016/s8756-3282(00)00344-6 · Cited by 154
Self-citationMoore, J. S., Monson, J. P., Kaltsas, G., Putignano, P., Wood, P. J., Sheppard, M. C., BESSER, G. M., Taylor, N., & Stewart, P. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6108 · Cited by 154
“The assessment of activity of these 11bHSD isozymes in man can be inferred from a 24-h urinary steroid metabolite profile by measuring the excretion of free and A ring-reduced F and E metabolites (14, 15 ).”
BackgroundSelf-citationLiquorice-induced rise in blood pressure: a linear dose-response relationship
Sigurjónsdóttir, H. Á., Franzson, L., Manhem, K., Ragnarsson, J., Sigurdsson, G., & Wallerstedt, S. (2001) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001215 · Cited by 143
Molecular Basis of Human Salt Sensitivity: The Role of the 11 -Hydroxysteroid Dehydrogenase Type 2
Lovati, E., Ferrari, P., Dick, B., Jostarndt, K., Frey, B. M., Frey, F. J., Schorr, U., & Sharma, A. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6098 · Cited by 150
“First, in the study by Litchfield et al. (28) only urinary-free cortisol but not cortisone or (THF15aTHF)/THE ratio were measured, thereby not allowing a direct evaluation of 11bHSD2 activity; second, a reduced 11bHSD2 activity correlates with a decreased urinary excretion of free cortisone rather than an increased ur…”
BackgroundInfluentialSteroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism
Storbeck, K.-H., Schiffer, L., Baranowski, E. S., Chortis, V., Prete, A., Barnard, L., Gilligan, L. C., Taylor, A. E., Idkowiak, J., Arlt, W., et al. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00262 · Cited by 141
Self-citationTomlinson, J., Finney, J., Gay, C., Hughes, B. A., Hughes, S. V., & Stewart, P. M. (2008) · Diabetes · doi:10.2337/db08-0495 · Cited by 132
“Urinary corticosteroid metabolite analysis was performed by gas chromatography/mass spectrometry (GC/MS) as described previously (20).”
BackgroundMethodInfluentialSelf-citationCA-Repeat polymorphism in intron 1 of HSD11B2 : effects on gene expression and salt sensitivity.
Agarwal, A. K., Giacchetti, G., Lavery, G., Nikkila, H., Palermo, M., Ricketts, M., McTernan, C., Bianchi, G., Manunta, P., Strazzullo, P., et al. (2000) · HYPERTENSION · doi:10.1161/01.hyp.36.2.187 · Cited by 139
Self-citationSeasonal Variation in Glucocorticoid Activity in Healthy Men1
Walker, B. R., Best, R., Noon, J. P., Watt, G. C. M., & Webb, D. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4430 · Cited by 133
“Inhibition of renal 11b-HSD2 results in higher ratios of free cortisol/cortisone in urine (13, 30 ) and suppression of plasma renin activity and aldosterone, which we did not observe in winter.”
BackgroundFerrari, P., Sansonnens, A., Dick, B., & Frey, F. J. (2001) · Hypertension · doi:10.1161/hy1101.096112 · Cited by 127
Gelding, S. V., Taylor, N. F., Wood, P. J., Noonan, K., Weaver, J. U., Wood, D. F., & Monson, J. P. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.3641180.x · Cited by 124
Yehuda, R., Bierer, L. M., Sarapas, C., Makotkine, I., Andrew, R., & Seckl, J. R. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.03.018 · Cited by 121
“5α-reductase activity was inferred from the ratio of 5α-THF/ F, and 5β-reductase activity, similarly from the ratio of 5β-THF/ F. 11β-HSD-2 activity was inferred from the ratio of E/ F; total 11β-HSD activity from the ratio (5α-THF + 5β-THF)/THE (Palermo et al., 1996).”
MethodGlucocorticoid Metabolism in Obesity and Following Weight Loss
Akalestou, E., Genser, L., & Rutter, G. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00059 · Cited by 133
“The A-ring reductases, 5-reductase types 1 and 2 (5R1 and 5R2) convert cortisol and cortisone to their dihydrometabolites, and these are next converted to tetrahydrometabolites through the action of 3-hydroxysteroid dehydrogenase (25, 26).”
BackgroundCortisol metabolism in hypertension
Hammer, F., & Stewart, P. M. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.001 · Cited by 124
Self-citationConsequences of weaning piglets at 21 and 28 days on growth, behaviour and hormonal responses
Colson, V., Orgeur, P., Foury, A., et al. (2005) · Applied Animal Behaviour Science · doi:10.1016/j.applanim.2005.08.014 · Cited by 119
Local and systemic glucocorticoid metabolism in inflammatory arthritis
Hardy, R., Rabbitt, E. H., Filer, A. D., Emery, P., Hewison, M., Stewart, P. M., Gittoes, N. J. L., Buckley, C. D., Raza, K., & Cooper, M. S. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.090662 · Cited by 118
Self-citationLiquorice and its health implications
Olukoga, A. O., & Donaldson, D. I. (2000) · The Journal of the Royal Society for the Promotion of Health · doi:10.1177/146642400012000203 · Cited by 119
A Switch in Hepatic Cortisol Metabolism across the Spectrum of Non Alcoholic Fatty Liver Disease
Ahmed, A., Rabbitt, E., Brady, T., Brown, C., Guest, P., Bujalska, I. J., Doig, C., Newsome, P. N., Hubscher, S., Elias, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029531 · Cited by 115
“Urine samples were analyzed by gas chromatography/mass spectrometry, as reported previously [18,19], measuring free and conjugated cortisol metabolites.”
MethodSelf-citationIncreased 5α-Reductase Activity and Adrenocortical Drive in Women with Polycystic Ovary Syndrome
Vassiliadi, D. A., Barber, T. M., Hughes, B. A., McCarthy, M. I., Wass, J. A. H., Franks, S., Nightingale, P., Tomlinson, J. W., Arlt, W., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0837 · Cited by 110
Modulation of glucocorticoid metabolism by the growth hormone – IGF‐1 axis
Agha, A., & Monson, J. P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02763.x · Cited by 108
Molecular Basis for Hypertension in the “Type II Variant” of Apparent Mineralocorticoid Excess
Li, A., Tedde, R., Krozowski, Z., Pala, A., Li, K. X. Z., Shackleton, C. H. L., Mantero, F., Palermo, M., & Stewart, P. M. (1998) · The American Journal of Human Genetics · doi:10.1086/301955 · Cited by 105
Self-citationStewart, P. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490163 · Cited by 102
Self-citationSinclair, A. J., Walker, E. A., Burdon, M., van Beek, A. P., Kema, I. P., Hughes, B. A., Murray, P. I., Nightingale, P., Stewart, P. M., Rauz, S., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0729 · Cited by 105
“Evaluation of papilledema by ultrasonographic measurement of optic disc height (20 MHzscan;QuantelMedical,Clermont-Ferrand,France)andheadache, via a Headache Impact Test-6 questionnaire (26), was carried out.”
MethodSelf-citationAlmoosawi, S., Fyfe, L., Ho, C. K. M., & Al‐Dujaili, E. A. S. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509992431 · Cited by 101
“This ratio serves as a measure of renal 11b-hydroxysteroid dehydrogenase type 2 activity((42)).”
Growth Hormone, Insulin-Like Growth Factor-I and the Cortisol-Cortisone Shuttle
Stewart, P. M., Toogood, A. A., & Tomlinson, J. W. (2001) · Hormone Research in Paediatrics · doi:10.1159/000048126 · Cited by 103
“The subsequent characterization of two 11β-HSD isozymes – a type 1 oxo-reductase converting E to F and a type 2 dehydrogenase inactivating F to E – led to further studies to define the action of GH in more detail. Because of the predominant renal expression of 11β-HSD2, the urinary free cortisol/urinary free cortisone…”
BackgroundSelf-citationJamieson, A., Wallace, E. M., Andrew, R., Nunez, B. S., Walker, B. R., Fraser, R., White, P. C., & Connell, J. M. C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6031 · Cited by 100
“The normal ratio of urinary free cortisol/cortisone and the absence of mineralocorticoid excess effectively exclude the possibility that the syndrome is accounted for by enhanced 11b-HSD2 activity in the kidney (27, 30 ).”
BackgroundTomlinson, J., Sherlock, M., Hughes, B., Hughes, S. V., Kilvington, F., Bartlett, W. A., Courtney, R., Rejto, P. A., Carley, W. W., & Stewart, P. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2325 · Cited by 98
Self-citationRasmuson, S., Andrew, R., Näsman, B., Seckl, J. R., Walker, B. R., & Olsson, T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01015-5 · Cited by 99
McWhinney, B. C., Briscoe, S., Ungerer, J. P. J., & Pretorius, C. J. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.08.044 · Cited by 97
11β-Hydroxysteroid Dehydrogenase Type 1 Activity Predicts the Effects of Glucocorticoids on Bone
Cooper, M. S., Blumsohn, A., Goddard, P. E., Bartlett, W. A., Shackleton, C. H. L., Eastell, R., Hewison, M., & Stewart, P. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-022025 · Cited by 97
Self-citationApparent mineralocorticoid excess syndrome: an overview
Palermo, M., Quinkler, M., & Stewart, P. M. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000500015 · Cited by 92
Self-citationRole of the 11β-hydroxysteroid dehydrogenase type 2 in blood pressure regulation
Ferrari, P., & Krozowski, Z. S. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00978.x · Cited by 94
“Moreover, a reduced 11bHSD2 activity correlates with a decrease in urinary excretion of free cortisone rather than an increased urinary free cortisol excretio”
BackgroundAndrew, R., Smith, K., Jones, G. C., & Walker, B. R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8157 · Cited by 91
Tomlinson, J. W., Finney, J., Hughes, B. A., Hughes, S. V., & Stewart, P. M. (2008) · Diabetes · doi:10.2337/db08-0094 · Cited by 91
“Urinary corticosteroid metabolite analysis was performed by gas chromatography/mass spectrometry as described previously (17).”
BackgroundMethodInfluentialSelf-citationWeight Loss Increases 11β-Hydroxysteroid Dehydrogenase Type 1 Expression in Human Adipose Tissue
Tomlinson, J., Moore, J. S., Clark, P. M. S., Holder, G., Shakespeare, L., & Stewart, P. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031376 · Cited by 93
“In addition, all patients performed a 24-hour urine collection for corticosteroid metabolite analysis using gas chromatography / mass spectrometry as previously described (9).”
Self-citationFinken, M. J. J., Andrews, R. C., Andrew, R., & Walker, B. R. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.6009 · Cited by 88
Cho, H.-J., Kim, J.-D., Lee, W., Chung, B. C., & Choi, M. H. (2008) · Analytica Chimica Acta · doi:10.1016/j.aca.2008.10.059 · Cited by 86
Penninkilampi, R., Eslick, E. M., & Eslick, G. D. (2017) · Journal of Human Hypertension · doi:10.1038/jhh.2017.45 · Cited by 86
Almoosawi, S., Tsang, C., Ostertag, L. M., Fyfe, L., & Al‐Dujaili, E. A. S. (2012) · Food & Function · doi:10.1039/c2fo30060e · Cited by 83
The role of the 11β-hydroxysteroid dehydrogenase type 2 in human hypertension
Ferrari, P., Lovati, E., & Frey, F. J. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018030-00001 · Cited by 83
Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
Gathercole, L., & Stewart, P. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.060 · Cited by 82
Self-citationHay, M., & Mormède, P. (1997) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(97)00361-7 · Cited by 79
Influence of short-term dietary weight loss on cortisol secretion and metabolism in obese men
Johnstone, A. M., Faber, P., Andrew, R., Gibney, E. R., Elia, M., Lobley, G. E., Stubbs, R. J., & Walker, B. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500185 · Cited by 79
“With increased ACTH-dependent cortisol production, inactivation of cortisol to cortisone by 11HSD2 may be impaired (52, 53), resulting in elevated urinary free cortisol/cortisone ( 38 ).”
BackgroundMethod11β-Hydroxysteroid Dehydrogenase Activity in Hypothalamic Obesity
Tiosano, D., Eisentein, I., Militianu, D., Chrousos, G. P., & Hochberg, Z. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020511 · Cited by 78
Adrenocortical activity in healthy children is associated with fat mass
Dimitriou, T., Maser‐Gluth, C., & Remer, T. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.3.731 · Cited by 76
Rauz, S., Cheung, C. M. G., Wood, P. J., Coca‐Prados, M., Walker, E. A., Murray, P. I., & Stewart, P. (2003) · QJM · doi:10.1093/qjmed/hcg085 · Cited by 75
Self-citationApparent mineralocorticoid excess
Wilson, R. C., Nimkarn, S., & New, M. I. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00356-8 · Cited by 75
Ferrari, P. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(03)00053-8 · Cited by 76
11β-Hydroxysteroid Dehydrogenase and Its Role in the Syndrome of Apparent Mineralocorticoid Excess
White, P. C. (2001) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200112000-00003 · Cited by 72
Tomlinson, J., Draper, N., Mackie, J., Johnson, A. P., Holder, G., Wood, P. J., & Stewart, P. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8189 · Cited by 81
Self-citationTsang, C., Smail, N. F., Almoosawi, S., Davidson, I., & Al‐Dujaili, E. A. S. (2012) · Journal of Nutritional Science · doi:10.1017/jns.2012.10 · Cited by 73
Trainer, P. J., Drake, W. M., Perry, L. A., Taylor, N., BESSER, G. M., & Monson, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7664 · Cited by 72
“We and others have previously demonstrated that GH does not alter the urinary free cortisol to cortisone ratio, indicating that the changes in Fm/Em and THF plus 5aTHF/THE ratios due to GH are specific to 11bHSD1 (1, 9 ).”
BackgroundMutants of 11β-Hydroxysteroid Dehydrogenase (11-HSD2) With Partial Activity
Nunez, B. S., Rogerson, F. M., Mune, T., Igarashi, Y., Nakagawa, Y., Phillipov, G., Moudgil, A., Travis, L. B., Palermo, M., Shackleton, C. H. L., et al. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.638 · Cited by 68
Self-citationSensitivity of bone to glucocorticoids
Cooper, M. S. (2004) · Clinical Science · doi:10.1042/cs20040070 · Cited by 68
Weaver, J. U., Taylor, N., Monson, J. P., Wood, P. J., & Kelly, W. F. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00494.x · Cited by 66
Hughes, K. A., Manolopoulos, K. N., Iqbal, J., Cruden, N. L. M., Stimson, R. H., Reynolds, R. M., Newby, D. E., Andrew, R., Karpe, F., & Walker, B. R. (2012) · Diabetes · doi:10.2337/db11-1345 · Cited by 64
“Most investigators relied upon measuring urinary free cortisol–to–cortisone ratios as an index of renal 11bHSD2 activity (33,34) or on urinary cortisol–to–cortisone metabolite ratios, which reflect predominantly intrahepatic steroid levels.”
BackgroundExpression and putative role of 11 beta-hydroxysteroid dehydrogenase isozymes within the human eye.
Rauz, S., Walker, E. A., Shackleton, C. H. L., Hewison, M., Murray, P. I., & Stewart, P. M. (2001) · PubMed · Cited by 61
Self-citationEsche, J., Shi, L., Sánchez‐Guijo, A., Hartmann, M. F., Wudy, S. A., & Remer, T. (2016) · Kidney International · doi:10.1016/j.kint.2016.02.033 · Cited by 62
Cortisol Metabolism in Depressed Patients and Healthy Controls
Römer, B., Lewicka, S., Kopf, D., Lederbogen, F., Hamann, B., Gilles, M., Schilling, C., Onken, V., Frankhauser, P., & Deuschle, M. (2009) · Neuroendocrinology · doi:10.1159/000235904 · Cited by 60
Toogood, A. A., Taylor, N., Shalet, S. M., & Monson, J. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6505 · Cited by 61
Walker, E. A., Ahmed, A., Lavery, G. G., Tomlinson, J., Kim, S. Y., Cooper, M. S., Ride, J. P., Hughes, B. A., Shackleton, C. H. L., McKiernan, P. J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704144200 · Cited by 60
Self-citationHenschkowski, J., Stuck, A. E., Frey, B. M., Gillmann, G., Dick, B., Frey, F. J., & Mohaupt, M. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.152 · Cited by 60
Glycyrrhizic acid suppresses type 2 11β-hydroxysteroid dehydrogenase expression in vivo
Tanahashi, T., Mune, T., Morita, H., Tanahashi, H., Isomura, Y., Suwa, T., Daido, H., Gómez-Sánchez, C. E., & Yasuda, K. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00033-x · Cited by 59
Ceccato, F., Antonelli, G., Barbot, M., Zilio, M., Mazzai, L., Gatti, R. D., Zaninotto, M., Mantero, F., Boscaro, M., Plebani, M., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0061 · Cited by 56
Self-citationCure of Apparent Mineralocorticoid Excess by Kidney Transplantation
Palermo, M., Cossu, M. L., & Shackleton, C. H. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812103392414 · Cited by 54
Self-citationTargeting Human Urinary Metabolome by LC–MS/MS: A Review
Rodríguez-Morató, J., Pozo, Ó. J., & Marcos, J. (2018) · Bioanalysis · doi:10.4155/bio-2017-0285 · Cited by 53
“Precursor/product ratios have proved to be the best markers for the diagnosis of many conditions [59-61].”
BackgroundClassic and Nonclassic Apparent Mineralocorticoid Excess Syndrome
Carvajal, C. A., Tapia-Castillo, A., Vecchiola, A., Baudrand, R. F., & Fardella, C. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz315 · Cited by 51
Painovich, J., SHUFELT, C. L., Azziz, R., Yang, Y., Goodarzi, M. O., Braunstein, G. D., Karlan, B. Y., Stewart, P. M., & Merz, C. N. B. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31821f9171 · Cited by 52
“THF, 5>-THF, cortolones, and cortols), along with the concentrations of free F and free estrodial, was used as an assessment of the total daily F production, as previously validated.(29)”
MethodSelf-citationHawley, J. M., & Keevil, B. G. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.05.014 · Cited by 54
Swords, F. M., Carroll, P., Kisalu, J., Wood, P. J., Taylor, N., & Monson, J. P. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01894.x · Cited by 52
Ontogeny and sexual dimorphic expression of mouse type 2 11β-hydroxysteroid dehydrogenase
Condon, J. C., Ricketts, M., Whorwood, C. B., & Stewart, P. M. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)04000-8 · Cited by 51
Self-citationQuinkler, M. O., Zehnder, D., Lepenies, J., Petrelli, M. D., Moore, J. S., Hughes, S. V., Cockwell, P., Hewison, M., & Stewart, P. M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01954 · Cited by 52
Self-citationMariniello, B., Ronconi, V., Sardu, C., et al. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.02.020 · Cited by 51
“Moreover an increased UFF/ UFE ratio, an index of 11 -HSD2 activity, has also been noted in salt-sensitive hypertensive patients.(22,24) The increased excretion of urinary cortisol metabolites in some patients with essential hypertension also argues for the involvement of 11 -HSD2 in hypertension.”
BackgroundMethodResultSelf-citationBuning, J. W., van Faassen, M. H. J. R., Brummelman, P., Dullaart, R. P. F., van den Berg, G., van der Klauw, M. M., Kerstens, M. N., Stegeman, C. A., Kobold, A. C. M., Kema, I. P., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2216 · Cited by 51
Woods, C. P., Corrigan, M., Gathercole, L., TAYLOR, A. E. R., Hughes, B. A., Gaoatswe, G., Manolopoulos, K. N., Hogan, A. E., O’Connell, J., Stewart, P. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4120 · Cited by 49
“Participants completed a 24-hour urine collection for cortisol, cortisone, and glucocorticoid metabolite analysis (38) before surgery and again after surgery, following weight loss.”
MethodSelf-citationTokarz, J., Mindnich, R., Norton, W., Möller, G., Hrabé de Angelis, M., & Adamski, J. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.022 · Cited by 48
Odermatt, A., Dick, B., Arnold, P., Zaehner, T., Plueschke, V., Deregibus, M. N., Repetto, H. A., Frey, B. M., Frey, F. J., & Ferrari, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7334 · Cited by 47
Khelil, M. B., Tegethoff, M., Meinlschmidt, G., Jamey, C., Ludes, B., & Raul, J. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5172-3 · Cited by 46
“23) recently determined by HPLC combined with fluorescence derivatization [32], indicating that the cortisol/cortisone ratio measured in nail may reflect the same physiological processes as the urinary ratio, above all the net balance of corticosteroid 11-betadehydrogenase isozyme 1 (HSD11B1) and corticosteroid 11-bet…”
Effect of Polyphenol-Rich Dark Chocolate on Salivary Cortisol and Mood in Adults
Tsang, C., Hodgson, L., Bussu, A., Farhat, G., & Al‐Dujaili, E. A. S. (2019) · Antioxidants · doi:10.3390/antiox8060149 · Cited by 47
“The ratio of cortisol to cortisone is well accepted by many researchers as indicative of 11β-HSD type 1 activity [29,36].”
BackgroundBäcklund, N., Brattsand, G., Israelsson, M., Ragnarsson, O., Burman, P., Edén Engström, B., Høybye, C., Berinder, K., Wahlberg, J., Olsson, T., et al. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0872 · Cited by 46
Mini-review of hair cortisol concentration for evaluation of Cushing syndrome
Hodes, A., Meyer, J., Lodish, M. B., Stratakis, C. A., & Zilbermint, M. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1517043 · Cited by 46
Campino, C., Carvajal, C. A., Cornejo, J., Martín, B. S., Olivieri, O., Guidi, G. C., Faccini, G., Pasini, F., Sateler, J., Baudrand, R. F., et al. (2009) · Endocrine · doi:10.1007/s12020-009-9269-9 · Cited by 46
Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients
Hoshiro, M., Ohno, Y., Masaki, H., et al. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02412.x · Cited by 44
Cortisol as a mineralocorticoid in human disease
Stewart, P. M. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00072-2 · Cited by 43
Self-citationKerstens, M. N., Riemens, S. C., Sluiter, W. J., Pratt, J. J., Wolthers, B. G., & Dullaart, R. P. F. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00975.x · Cited by 43
Cohen, J., Lassig‐Smith, M., Deans, R., Pretorius, C. J., Ungerer, J. P. J., Tan, T. C. H., Jones, M., & Venkatesh, B. (2011) · Shock · doi:10.1097/shk.0b013e318239b809 · Cited by 43
Yamashita, K., Nakagawa, R., Okuyama, M., Honma, S., Takahashi, M., & Numazawa, M. (2008) · Steroids · doi:10.1016/j.steroids.2008.02.009 · Cited by 41
Genetic manipulation of 11β-hydroxysteroid dehydrogenases in mice
Paterson, J. M., Seckl, J. R., & Mullins, J. J. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00017.2005 · Cited by 40
Metadata
- Authors
- Palermo, M., Shackleton, C. H. L., Mantero, F., & Stewart, P. M.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- Corresponding author
- Stewart, Paul M.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1996-11
- Volume
- 45
- Issue
- 5
- Pages
- 605-611
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2019500301
- Cited by
- 276
- References
- 0
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 6 · 2020: 9 · 2019: 11 · 2018: 4 · 2017: 5 · 2016: 6 · 2015: 6 · 2014: 10 · 2013: 9 · 2012: 12
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- urinary free cortisol, 11β-hydroxysteroid dehydrogenase type 2, tetrahydrocortisone, tetrahydrocortisol, Cushing's syndrome, ectopic ACTH syndrome, hypopituitarism, hydrocortisone replacement, apparent mineralocorticoid excess, licorice, hypertension, pituitary-adrenal axis
- MeSH terms
- Adult, Child, Cortisone, Cushing Syndrome, Female, Glycyrrhiza, Humans, Hydrocortisone, Hydroxysteroid Dehydrogenases, Hypopituitarism, Male, Gas Chromatography-Mass Spectrometry, Middle Aged, Mineralocorticoids, Pituitary-Adrenal System, Plants, Medicinal, Tetrahydrocortisol, Tetrahydrocortisone, 11-beta-Hydroxysteroid Dehydrogenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
